| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Adamantane–sclareol hybrids selectively target multidrug resistant glioblastoma cells by inducing oxidative stress | Lupšić, Ema | Conference Paper | Mp. category will be shown later |
| 2025 | Impact of ex vivo cell culturing on ABC transporters' expression and drug sensitivity in patient-derived non-small cell lung cancer models![]() | Dinic, Jelena B | Article | 22M22 |
| 2025 | Development and Characterization of a Temozolomide-Resistant Human Glioblastoma Cell Line | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells | Lupšić, Ema | Article | 21M21 |
| 2025 | Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Koračak, Ljiljana; Ajdačić, Vladimir | Article | 21aM21a |
| 2025 | Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures | Podolski-Renić, Ana | Article | 22M22 |
| 2025 | Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung Cancer | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2025 | Two novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | LB-100 Enhances Drugs Efficacy through Inhibition of P-glycoprotien Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models | Podolski-Renić, Ana | Article | 21aM21a |
| 2025 | Development of a Clinically Relevant Temozolomide-Resistant Human Glioblastoma A-172 Cell Line | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells![]() | Stojković, Pavle | Article | 21aM21a |
| 2024 | Advancements in Personalized Therapy for Non-Small Cell Lung Carcinoma: The Role of Functional Diagnostics![]() | Dinić, Jelena | Conference Paper | Mp. category will be shown later |
| 2024 | Synthesis of Artesunate-Pyrimidine Hybrids and Evaluation of Their Activity Against Multidrug-Resistant Cancer Cells | Koračak, Ljiljana; Selaković, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors | Dinić, Jelena | Article | 21M21 |
| 2024 | Optimizing Treatment Response in Lung Squamous Cell Carcinoma by Cell-Based Functional Sensitivity Screening | Podolski-Renić, Ana | Article | Mp. category will be shown later |
| 2024 | Integrating functional screening and bioinformatics for personalized medicine approaches in NSCLC | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2024 | Functional diagnostics in non-small cell lung carcinoma - the potential for personalized approach | Lupšić, Ema | Conference Paper | Mp. category will be shown later |
| 2024 | Synthesis and anticancer activity of novel sclareol derivatives | Ajdačić, Vladimir; Stojković, Pavle; Nikolić, Andrea; Andrijević, Ana; Lupšić, Ema | Conference Paper | Mp. category will be shown later |
| 2024 | Functional Diagnostics in Personalized Therapy for Non-Small Cell Lung Carcinoma | Podolski-Renić, Ana | Conference Paper | Mp. category will be shown later |
| 2024 | The Use of Pyrimidines in Medicinal Chemistry: Derivatives with Artesunic Acid | Nikolić, Andrea M.; Koračak, Ljiljana; Lupšić, Ema | Conference Paper | Mp. category will be shown later |